MichaelMillensonMD
Hematology • Philadelphia, PAHematologic Oncology
Director of Hematology, Fox Chase Cancer Center
Dr. Millenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
# Fox
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-728-3639
Education & Training
Temple University HospitalResidency, Internal Medicine, 1984 - 1987
Lewis Katz School of Medicine at Temple UniversityClass of 1984
Certifications & Licensure
PA State Medical License 1985 - 2024
NJ State Medical License 1988 - 1991
ME State Medical License Active through 1988
NC State Medical License 1987 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 38 citationsPhase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017.Hossein Borghaei, Corey J. Langer, Michael Millenson, Karen Ruth, Samuel Litwin
Journal of Thoracic Oncology. 2008-11-01 - 33 citationsRadiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.Bouthaina S. Dabaja, Ann Vanderplas, Allison Crosby-Thompson, Gregory A. Abel, Myron S. Czuczman
Cancer. 2015-04-01 - 109 citationsCancer-associated venous thromboembolic disease, version 1.2015: Featured updates to the NCCN GuidelinesMichael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani, Paula L. Bockenstedt, Carolyn M. Chesney
Journal of the National Comprehensive Cancer Network. 2015-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
